Before approving Mots-C (10mg / 40mg) for internal use, align catalog data with batch COA records. Mots-C Specification and Vial Format Review focuses on Mitochondrial Research sourcing via sulanpeptide.vip.
Mots-C is a mitochondria-derived peptide used in laboratory research on mitochondrial signaling, metabolic pathway models, cellular stress-response systems, and peptide-regulated energy-balance research.
Research examines MOTS-c effects on glucose uptake in myotube cultures and on exercise-mimetic transcriptomic signatures in rodent models. AMPK phosphorylation Western blots, glucose uptake (2-DG) assays, and mitochondrial stress tests (Seahorse OCR) are published readouts.
Lee et al. and follow-up groups identified MOTS-c as a mitokine linking mitochondrial dysfunction to nuclear metabolic gene programs. MOTS-c is a mitochondria-encoded 16-amino-acid peptide translocated to nucleus under metabolic stress, influencing AMPK pathway gene expression.
Principal investigators should sign off Mots-C SKUs only after mechanism fit is documented in the study protocol. Spec alignment: Enter exact strength notation (10mg / 40mg) in procurement systems—do not round kit counts.
Side-by-side review of specification table, vial label, and COA prevents release errors for Mots-C.
Catalog identifiers for Mots-C: CAS 1627580-64-6, Formula: C101H152N28O22S2. MW 2174.6 g/mol, purity target ≥ 99.0%. Copy these fields into requisitions and match them line-by-line on incoming COA PDFs.
Dose planning for Mots-C should state mass (10mg / 40mg) or molarity derived from catalog molecular weight.
Publication methods should list Cat No. and mg strength for Mots-C to support reproducibility.
Molecular identifiers for Mots-C—CAS 1627580-64-6, molecular weight, and formula when listed—should appear on internal sample labels alongside Cat No. Publications citing Mots-C should include these fields for reproducibility in Mitochondrial Research journals. Format selection for Mots-C affects reconstitution math and aliquot planning. Compare available vial strengths on sulanpeptide.vip against protocol dose ranges before leadership approves a SKU; changing strength mid-study complicates comparability.
Side-by-side review of catalog specification table, quote confirmation, vial label, and COA prevents release errors for Mots-C. QA sign-off should reference all four documents in the batch record. Purity target ≥ 99.0% on the catalog is a specification goal. Release criteria for Mots-C should state whether the lot COA must meet or exceed that threshold for your Mitochondrial Research assay type.
Specification alignment for Mots-C requires copying exact kit notation (10mg / 40mg) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits.
Purity target ≥ 99.0% on the catalog is a specification goal. Release criteria for Mots-C should state whether the lot COA must meet or exceed that threshold for your Mitochondrial Research assay type. Specification alignment for Mots-C requires copying exact kit notation (10mg / 40mg) into ERP or LIMS systems. Rounding “10mg×10 vials” to “100mg total” causes mismatches when COA lists per-vial strength and suppliers ship multi-vial kits.
Side-by-side review of catalog specification table, quote confirmation, vial label, and COA prevents release errors for Mots-C. QA sign-off should reference all four documents in the batch record.
Mots-C from Sulan Peptide Official is for research use only (RUO)—not for human or veterinary use. Questions: Contact page or WhatsApp on sulanpeptide.vip.